ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FDA Approval of Lung Transplant Device

Monday, March 24, 2014

Submitted by

Author(s)

C Phend

On March 20, 2014, a panel of the FDA gave unanimous approval for use of an ex-vivo perfusion system for improving the quality of explanted lungs prior to transplantation.  If this recommendation is followed by the FDA, such devices could be used clinically under IRB protocols.

Add comment

Log in or register to post comments